Retinal vein occlusion and macular edema – critical evaluation of the clinical value of ranibizumab

Retinal vein occlusions (RVOs) constitute the second most common cause of retinal vascular disease after diabetic retinopathy, with a prevalence of between 1% and 2% in persons older than 40 years of age. Despite the existence of numerous potential therapeutic options, none is entirely satisfactory,...

Descripción completa

Detalles Bibliográficos
Autores principales: Keane, Pearse A, Sadda, Srinivas R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130914/
https://www.ncbi.nlm.nih.gov/pubmed/21750610
http://dx.doi.org/10.2147/OPTH.S13774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130914/
https://www.ncbi.nlm.nih.gov/pubmed/21750610
http://dx.doi.org/10.2147/OPTH.S13774

Ejemplares similares